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Abstract
Introduction: Mesonephric adenocarcinoma of uterine cervix is a rare variant of primary endocervical adenocarcinoma and a few
cases have been reported previously. In fact in non-metastatic adenocarcinoma of the cervix, less than 5% possess mesonephric type.
Because of the low incidence of mesonephric adenocarcinoma, various methods have been proposed for treatment of mesonephric
adenocarcinoma. Nevertheless, there is no unity in treatment approaches.
Case Presentation: Here, we present a 45-year woman who had bloody discharge for 6 months period. Hormonal profile such as
thyroid stimulating hormon (TSH) and prolactin was normal and all imaging studies showed a cervical fibroma as a mass. Abdomi-
nal hysterectomy -bilateral salpingectomy was performed. After pathologic report as a mesonephric adenocarcinoma, she received
radiation and then she was candidate for bilateral oophorectomy.
Conclusions: Because of the diversity and an unusual appearance of mesonephric adenocarcinoma with aproblematic case of cer-
vical mass, it is very important to consider mesonephric adenocarcinoma as a type of diagnosis. Numerous differential diagnoses
should be considered for management of this type of carcinoma. In order to make a diagnosis, deep biopsy of infiltrative mass of
uterine cervix, is mandatory.
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1. Introduction
Between the gynecological cancers, in terms of inci-
dence and mortality cervical cancer is the third most com-
mon type of cancer in the United States, after endometrial
carcinoma and ovarian carcinoma (1).
Histologically, 69 percent of uterine cervical cancer has
squamous and 25 percent contain adenocarcinoma cell
type (2). In fact in non-metastatic adenocorcinoma of the
cervix, less than 5% possess mesonephric type (3). Malig-
nant mesonephric tumors derived from remnants of the
paired mesonephric (Wolffian) ducts. Due to limited cases
of mesonephric adenocarcinoma of the cervix, no optimal
management or prognosis has been reported so far. Some
studies are suggesting a tendency for multiple recurrence
and others, an associated aggressive clinical course (4-6).
The clinical profile of adenocarcinoma of the cervix does
not appear to differ from that of squamous cell cancer (7).
2. Case Presentation
We present a 45-year-woman who referred to our gyne-
cology oncology center Valiasr hospital in Tehran Univer-
sity of Medical Sciences with a 6-months history of bloody
vaginal discharge. She was gravida 3 and para 3, her past
medical history was unremarkable. There was no signif-
icant problem in her family history. On the initial physi-
cal examination there was only asymmetric hypertrophic
cervix, prominent in posterior lip without any ulceration.
It was very difficult to make a diagnosis, as a cervix fibroid,
and the vaginal sonography demonstrated endometrial
thickness 6 mm with normal size uterus. There was a mass
like lesion such as fibroid at the posterior lip of the cervix
measuring 4× 5 cm.
In another center, dilatation and curettage has been
performed and pathologist reported proliferative en-
dometrium and mild chronic cervicitis with squamous
metaplasia. We have performed a cervical biopsy, report-
ing only mild chronic cervicitis with reactive atypia of
epithelial cells. MRI reported cervical mass measuring 40
× 30 mm with mass effect higher on cervical canal. Lesion
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enhancement is lesser than myometrium, no extension
toward parametrium, vaginal canal and/ or uterus body.
The patient underwent a simple abdominal hysterectomy
and bilateral salpingectomy and ovaries were preserved
because of the age of patient. She had a satisfactory post-
operation course and discharged from hospital after three
days. Following operation, the microscopic examination
was mesonephric adenocarcinoma of cervix uteri with
histologic grade: moderately to poorly differentiated and
tumor size was 4.5 cm with depth of stromal invasion of
2 cm (Figure 1). The radial margin was free of tumor and
distance of tumor from closest margin was 2 mm, but
perineural and lympho vascular invasion was present. The
vaginal cuff margin was free of tumor. One paratubal cyst
and hyperplastic feature was also reported at the field as
atypical endometrial hyperplasia. Because of the depth of
invasion into stroma and lymphovascular space, adjuvant
chemo radiation included external and internal radiation
was accomplished, and no complications was observed
after adjuvant treatment. Now, nine months after surgery,
she is free from any indication of disease and candidates
for second surgery for resection of ovaries.
Figure 1. Moderately to Poorly Differentiated and Tumor Size Was 4.5 cm With Depth
of Stromal Invasion of 2 cm
3. Discussion
In 1903 for the first time, mesonephric adenocarci-
noma was described by Meyer as a tumor of uterine cervix
apparent from remnant of mesonephric duct (8). The
pathologic feature of mesonephric adenocarcinoma is var-
ied and may include mullerian system and urogenital si-
nus (9). Differential diagnosis from other cervical carcino-
mas is difficult and limited information is known regard-
ing to its biological behavior, prognosis, and the optimal
management strategy (10).
Contrary to endocervical type adenocarcinoma, it has
no relation with human papilloma virus (HPV) infection.
Its diagnosis can be mistaken with other adenocarcinoma
morphologically. In addition, it may have a better prog-
nosis than mullerian counterparts. Mixture morphology
is the difficulty of correct diagnosis in small biopsy spec-
imen. Pathologists should consider this tumor very care-
fully as it shows various different morphologies (11).
Because of the rare report of such cases there is no
unity in treatment approachesand various methods have
been used for diagnosis or prognosis of mesonephric ade-
nocarcinoma of the cervix (12). There is numerous differen-
tial diagnoses including adenoma malignum, endometri-
oid and clear cell adenocarcinomas, and mesonephric hy-
perplasia (13).
Mesonephric adenocarcinoma often is visible deep
posterolaterally at the cervix. Our case was also located in
the same position (4). The median age at diagnosis of cer-
vical cancer in the United States from 2000 to 2004 was
48 years old (14). In mesonephric carcinoma, the age at
diagnosis is 30 to 50 years, our patient was 45 as men-
tioned (15). Small cell carcinoma of the uterine cervix is
the most common type, but especially in the younger age.
The adenocarcinoma type of uterine cervical cancer has
increased statistically in many reports recently (16). The
most common symptom at presentation for cervical can-
cer is abnormal vaginal bleeding and post coital bleed-
ing. Mesonphric adenocarcinoma is the same, at phys-
ical examination and imaging. Yap et al. reported in
25% of 26 cases, first diagnosis was in favor of cervical fi-
broid (15). The age and symptoms of our case are consis-
tent with previous case reports at presentation and early
stage of disease. It is important to accurately distinguish
mesonephric adenocarcinoma from benign, proliferative
mesonephric lesions. The latter encompasses a wide clin-
ical and pathologic spectrum with some lesions resulting
in clinical symptoms and displaying a diffuse hyperplastic
process that may have a deep infiltrative appearance (17).
It is hard to determine risk factors for the development
of mesonephric lesions and carcinoma. The natural his-
tory of this unusual tumor remains uncertain with some
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mesonephric adenocarcinomas displaying an aggressive
clinical course. Several cases of metastatic disease and/or
poor outcomes in the presence and absence of a malig-
nant sarcomatoid component have been described. So, as
suggested in previous reports, all recommendations for di-
agnosis of mesonephric adenocarcinoma uterine cervix,
treatment option, root of surgery, indication of adjuvant
therapy and follow up are similar to guidelines and pro-
tocols who described for usual histologic type of adeno-
carcinoma of the cervix according to clinical staging and
pathological examination (15). According to suggestion of
the gynecologic oncology group study #92 our patient, re-
ceived adjuvant chemo-radiation therapy (18). In conclu-
sion, because of the diversity and an unusual appearance
of mesonephric adenocarcinoma, when there is no exact
and definite diagnosis of cervical mass, rare histologic type
such as mesonephric adenocarcinoma should be consid-
ered and it is important to perform deep biopsy of infil-
trative mass of uterine cervix, in order to make an exact
diagnosis. Because of the low incidence of mesonephric
adenocarcinoma, there is various methods for treatment
of mesonephric adenocarcinoma. Nevertheless there is no
unity in treatment approaches.
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